NEUROFARMACOLOGIA DEL DOLOR
NEUDOL
Harvard University
Cambridge, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard University (3)
2022
-
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer
Science Translational Medicine, Vol. 14, Núm. 660
2014
-
Diminished Schwann cell repair responses underlie age-associated impaired axonal regeneration
Neuron, Vol. 83, Núm. 2, pp. 331-343
1996
-
Effects of a single bout of ultraendurance exercise on lipid levels and susceptibility of lipids to peroxidation in triathletes
Journal of the American Medical Association, Vol. 276, Núm. 3, pp. 221-225